<DOC>
	<DOCNO>NCT00361946</DOCNO>
	<brief_summary>To study postprandial metabolism lean , obese T2DM adolescent use mixed meal challenge . Specifically measure follow parameter postprandial metabolism : 1 . Postprandial glucose triglyceride excursion 2 . Gastric empty 3 . Insulin , amylin , glucagon , GLP-1 ghrelin secretion 4 . Glucose Turnover rate</brief_summary>
	<brief_title>The Role Amylin Incretins Postprandial Metabolisms Adolescents With Type 2 Diabetes Mellitus ( T2DM ) .</brief_title>
	<detailed_description>Previously type 2 diabetes mellitus ( T2DM ) consider disease adult ; however , incidence T2DM child rise . Consequently , complication may occur early age , underscore importance improve glycemic control pediatric population . Postprandial hyperglycemia contribute significantly poor glycemic control T2DM . We understand addition insulin hormone ( glucagon , amylin GLP-1 ) may play role postprandial glucose metabolism . The role gastric empty increasingly recognize important factor regulate glucose appearance circulation . Abnormalities pancreatic hormone amylin incretin GLP-1 emerge contributor alteration gastric empty postprandial hyperglycemia T2DM . Although much know abnormality relate postprandial hyperglycemia adult T2DM , little information available pediatric population . This protocol examine gastric emptying , glucagon , GLP-1 amylin secretion healthy lean , obese child without diabetes post-ingestion mixed meal . The subject age Tanner stage match . The goal project well understand metabolic adaptation postprandial glucose homeostasis T2DM comparing study group obese ( normal glucose tolerance ) healthy ( lean ) control . The long-term goal PI use data gather protocol develop K-23 proposal incorporate new therapeutic option use amylin GLP-1 analog child T2DM improve postprandial hyperglycemia .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Incretins</mesh_term>
	<criteria>1 . Group A Lean Adolescents . Inclusion criterion : This group consist 20 lean adolescent age 1218 year , Tanner stage 35 pubertal development , BMI less 85th 20th age HbA1C le equal 6 % ( normal range 46 % ) . They take medication . A DXA scan perform estimate lean fat body mass . The body fat mass less equal 25 % include group ( lean range ) . The subject match age Tanner stage subject Group B C. Menstruating female must negative urine pregnancy test inclusion.The subject must weigh 43 kg . 2 . Group B Obese Adolescents . Inclusion criterion : This group consist obese adolescent , age 1218 year Tanner stage 35 pubertal development . They must : BMI equal 95th age , great 40 kg/m2 . They must normal glucose tolerance , word subject undiagnosed impair glucose tolerance diabetes consider study . To test diabetes impair glucose tolerance undergo 2hour Glucose tolerance test ( 2hrGTT ) . The ADA criterion use diagnosis diabetes and/or impaired glucose tolerance ( fast plasma glucose &lt; 110 mg/dl 2 hour postprandial blood glucose &lt; 140 mg/dl ) . They must normal liver function test take medication . The subject undergo DXA scan estimation total lean fat body mass . The fat mass equal 30 % consider obese . The subject group match age ( plus minus 1year ) , Tanner stage ( plus minus 1 ) body fat mass ( plus minus 5 % ) Type 2 diabetes adolescent ? . Menstruating female must negative urine pregnancy test inclusion . 3 . Group C T2DM Adolescents . Inclusion criteria The study group consist adolescent T2DM , age 1218 year , Tanner stage 35 pubertal development , BMI equal 85th age ( le 40 kg/m2 ) HbA1c le 8.5 % . They must T2DM diagnose least 2years , treat diet , oral hypoglycemic agent insulin . If medication need stable dose insulin / oral hypoglycemic agent last 2 month . The subject must otherwise healthy except hypothyroidism stable treatment . Menstruating female must negative urine pregnancy test inclusion . 1 . Group A Lean Adolescents a. Exclusion criterion : The subject exclude : history chronic disease ( leukemia , asthma , inflammatory bowel disease , cystic fibrosis , juvenile rheumatoid arthritis , etc ) , allergy local anesthetic ( ELAMAX Cream ) , evidence history chemical abuse , anemia elevate liver enzyme ( AST 80 U/L ALT 110 U/L ) . 2 . Group B Obese Adolescents a. Exclusion criterion : The exclusion criterion control group A . 3 . Study Group C T2DM Adolescents . The exclusion criterion control group one addition , subject may admit hospital diabetic ketoacidosis last 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Lean</keyword>
	<keyword>Obese</keyword>
</DOC>